Oracle Investment Management as of Sept. 30, 2017
Portfolio Holdings for Oracle Investment Management
Oracle Investment Management holds 20 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Tesaro | 27.8 | $146M | 1.1M | 129.10 | |
| Mazor Robotics Ltd. equities | 20.9 | $110M | 2.2M | 49.37 | |
| Quidel Corporation | 20.2 | $106M | 2.4M | 43.86 | |
| Pacific Biosciences of California (PACB) | 8.7 | $46M | 8.7M | 5.25 | |
| Opko Health (OPK) | 4.8 | $25M | 3.6M | 6.86 | |
| Amarin Corporation (AMRN) | 4.2 | $22M | 6.3M | 3.50 | |
| Vermillion | 3.4 | $18M | 9.8M | 1.80 | |
| Biolase Technology | 2.1 | $11M | 18M | 0.60 | |
| Accelr8 Technology Corporation | 1.9 | $10M | 5.2M | 1.96 | |
| shares Agenus | 1.3 | $7.0M | 1.6M | 4.41 | |
| Epizyme | 1.3 | $7.0M | 369k | 19.05 | |
| Adaptimmune Therapeutics (ADAP) | 1.1 | $5.7M | 702k | 8.19 | |
| Intrexon | 0.7 | $3.7M | 195k | 19.01 | |
| Contrafect | 0.5 | $2.4M | 2.2M | 1.11 | |
| Biogen Idec (BIIB) | 0.4 | $2.0M | 6.4k | 313.13 | |
| Accuray Incorporated (ARAY) | 0.4 | $1.9M | 473k | 4.00 | |
| Arena Pharmaceuticals | 0.3 | $1.6M | 64k | 25.51 | |
| NxStage Medical | 0.1 | $310k | 2.1M | 0.15 | |
| Aquabounty Technologies | 0.0 | $87k | 12k | 7.13 | |
| Second Sight Med Prods | 0.0 | $61k | 51k | 1.20 |
